1. Home
  2. ELTX vs CMRX Comparison

ELTX vs CMRX Comparison

Compare ELTX & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • CMRX
  • Stock Information
  • Founded
  • ELTX 2011
  • CMRX 2000
  • Country
  • ELTX United States
  • CMRX United States
  • Employees
  • ELTX N/A
  • CMRX N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • CMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELTX Health Care
  • CMRX Health Care
  • Exchange
  • ELTX Nasdaq
  • CMRX Nasdaq
  • Market Cap
  • ELTX 49.7M
  • CMRX 77.0M
  • IPO Year
  • ELTX 2021
  • CMRX 2013
  • Fundamental
  • Price
  • ELTX $4.16
  • CMRX $0.93
  • Analyst Decision
  • ELTX Buy
  • CMRX Strong Buy
  • Analyst Count
  • ELTX 2
  • CMRX 1
  • Target Price
  • ELTX $10.00
  • CMRX $11.00
  • AVG Volume (30 Days)
  • ELTX 16.1K
  • CMRX 119.4K
  • Earning Date
  • ELTX 11-07-2024
  • CMRX 11-08-2024
  • Dividend Yield
  • ELTX N/A
  • CMRX N/A
  • EPS Growth
  • ELTX N/A
  • CMRX N/A
  • EPS
  • ELTX N/A
  • CMRX N/A
  • Revenue
  • ELTX N/A
  • CMRX $144,000.00
  • Revenue This Year
  • ELTX N/A
  • CMRX $3,040.12
  • Revenue Next Year
  • ELTX N/A
  • CMRX N/A
  • P/E Ratio
  • ELTX N/A
  • CMRX N/A
  • Revenue Growth
  • ELTX N/A
  • CMRX N/A
  • 52 Week Low
  • ELTX $2.96
  • CMRX $0.75
  • 52 Week High
  • ELTX $11.45
  • CMRX $1.30
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 40.82
  • CMRX 60.78
  • Support Level
  • ELTX $4.05
  • CMRX $0.80
  • Resistance Level
  • ELTX $4.89
  • CMRX $0.98
  • Average True Range (ATR)
  • ELTX 0.28
  • CMRX 0.05
  • MACD
  • ELTX -0.06
  • CMRX 0.01
  • Stochastic Oscillator
  • ELTX 27.37
  • CMRX 83.33

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About CMRX Chimerix Inc.

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

Share on Social Networks: